The global nucleic acid testing market is expected to reach $3.7 billion by 2023. The market is expected to reach US$ 7.2 billion by 2033, growing at a healthy 6.8% CAGR.
Increased government and private sector investment in the development of novel biotechnological diagnostic techniques, as well as high demand for technologically advanced diagnostic measures, are expected to drive growth in the nucleic acid testing market.
Request a report sample to gain comprehensive insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1106
Nucleic acid testing is a new age testing practice that helps in detection, diagnosis and screening of pathogens even when there is no relative clinical sign for a health condition. Due to the assistance provided by nucleic acid testing to healthcare centres and common public, the market is expected to have positive prospects in coming years.
Nucleic Acid Testing Market: Overview
Nucleic acid testing is helpful in the detection of the nucleic acids such as viral DNAs or RNAs in specimen samples of the patients. The technique is helpful in providing special assistance to doctors as well as patients. The healthcare industry needs advanced technique to cope with the increasing severity of health-related issues that the population is more prone to. Increasing chronic disease incidences due to changing lifestyle have resulted in escalating demand for diagnostic procedures worldwide. Nucleic acid testing kits and consumables are the key products in the in-vitro diagnostic industry, as they have been proven to deliver promising results during critical diagnosis in various applications.
Emerging countries in the Asia Pacific region, such as China and India, are the hotspots for investments because of higher growth rate of diagnosis, treatment and research activities. Future Market Insights expects developing regional markets to experience higher demand for nucleic acid testing over the assessment period. According to the report, North America is expected to hold a market value of over US$ 1,600 Million by the end of 2027 but APAC is expected to create more incremental opportunities and will reportedly witness a CAGR of 8.6% during the forecast period.
Nucleic Acid Testing Market: Trends
Looking at the recent demands for nucleic acid testing, key manufacturers are now focusing on introducing new custom product offerings for specific needs. Due to the research community’s ever evolving needs, the demand for specialised tools and reagents have grown to the point where most vendors who are currently offering these products cannot depend solely on sales of catalog products. Customised products are likely to trend in near future, creating attractive growth opportunities for emerging businesses.
The rise in demand has also encouraged many companies to look for expansion of their businesses. Various companies are emphasizing on expansion activities by setting-up their plants and regional offices in developing regions, including APAC and MEA. The competitive scenario of the market is consolidated, and a majority players prefer to involve in sales and service agreements, collaborations, R&D, new product launches, joint ventures, partnerships, patent transfers, and mergers and acquisitions.
Nucleic Acid Testing Market by Category
- Nucleic Acid Test Kits
- Transcription-Mediated Amplification (TMA)
- Polymerase Chain Reaction (PCR)
- Ligase Chain Reaction (LCR)
- Whole Genome Sequencing
- Infectious diseases
- Forensic Testing
- Pathology laboratories
- Research Institutes
Customization Available@ https://www.futuremarketinsights.com/customization-available/rep-gb-1106
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
For Sales Enquiries: firstname.lastname@example.org
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs